Latest Breaking News On - Intensity therapeutics - Page 2 : comparemela.com

Intensity Therapeutics : Failure to Satisfy Listing Rule - Form 8-K

Item 3.01 Notice of Delisting or Failure to Satisfy a Listing Rule or Standard; Transfer of Listing. On April 12, 2024, Daniel Donovan resigned from the.

Daniel-donovan
Corporate-governance-committee
Audit-committee
Nasdaq
Securities-exchange
Nasdaq-stock-market
Board-compensation-committee
Listing-rule
Intensity-therapeutics
Compensation-committee
Corporate-governance
Nasdaq-listing-rule

Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8

/PRNewswire/ Intensity Therapeutics, Inc. (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of.

New-york
United-states
Justin-kulik
Jules-abraham
Lewish-bender
Intensity-therapeutics-inc
Sofitel-hotel
Nasdaq
Intensity-therapeutics
Chief-executive-officer
Dean-summers
Relations-contact

INTS Stock Earnings: Intensity Therapeutics Beats EPS for Q4 2023

INTS Stock Earnings: Intensity Therapeutics Beats EPS for Q4 2023
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Intensity-therapeutics
Place-earnings

Portage Biotech Completes Monetization of Intensity

Company generated approximately $2.8M of non-dilutive funding to extend cash runway.

United-states
American
Ian-walters
Nasdaq
Portage-biotech-inc
Linkedin
Society-for-immunotherapy-of-cancer
Company-annual-report-on-form
American-society-of-clinical-oncology
Intensity-therapeutics
Clinical-oncology
Annual-meeting

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
United-states
British
American
Ian-walters
Company-board-of-directors
Trial-safety-committee
Owners-of-the-company
Company-annual-report-on-form
Linkedin
Nasdaq
American-society-of-clinical-oncology